Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Endometrial Adenocarcinoma × GSK2141795 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 3 Endometrial Neoplasms 2 Triple Negative Breast Neoplasms 1 Lymphoma 1 Endometrial Adenocarcinoma 1 Breast Neoplasms 1

Interventions

trametinib 1 Radiotherapy 1 Radiation 1 GSK2141795 1 Doxorubicin 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01935973 2020-10-14

Trametinib With or Without GSK2141795 in Treating Patients With Recurrent or Persistent Endometrial Cancer

National Cancer Institute (NCI)

Phase 1 Completed

Endometrial Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡